Cipla
Tushar Katariya is a Senior Executive at Cipla, having joined the company in January 2024. Prior to this role, Tushar worked as a Senior Executive in Quality Assurance at Zydus Group from August 2021 to January 2024, and served as a Junior Officer in the Quality Assurance department at Acme Generics LLP from September 2020 to August 2021. Tushar began a career in quality assurance as a QA Trainee at Graviti Pharmaceuticals from July 2019 to August 2020. Tushar holds a Master of Pharmacy degree from Savitribai Phule Pune University, earned between August 2019 and July 2021.
This person is not in any teams
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.